Key facts
- This page summarizes Michael E. Prevoznik's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2026, 17:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Tax liability
Tax liability
Sale
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Represents an award of restricted stock units.
Footnote F2
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
Footnote F3
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Footnote F4
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Footnote F5
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.